Agodokpessi Gildas, Aït-Khaled Nadia, Gninafon Martin, Tawo Leon, Bekou Wilfried, Perrin Christophe, Bissell Karen, Billo Nils, Enarson Donald A, Chiang Chen-Yuan
Centre National Hospitalier de Pneumo phtisiolologie, Cotonou, Bénin.
International Union Against Tuberculosis and Lung Disease, 68, boulevard Saint-Michel, 75006 Paris, France.
J Pharm Policy Pract. 2015 Apr 13;8(1):12. doi: 10.1186/s40545-015-0033-7. eCollection 2015.
Benin established a revolving drug fund (RDF) for essential asthma medicines in 2008. We evaluated the operation of the RDF and assessed whether there was interruption of supply of asthma medicine from 2008 to 2013.
We reviewed the process in establishing the RDF. We assessed cost and sale price of asthma medicines, expenditure of the RDF in procuring asthma medicines and other tools, revenue generated by sales of medicines to patients, and balance of capital as of 31 January 2013. We investigated whether there was interruption of supply of essential asthma medicines from 2008-2013.
The total amount of grants initially injected into the RDF was 24,101€. As of 31 January 2013, the capital of the RDF, including the deposit in the RDF bank account (8,114€) and the value of inhalers in stock (12,172€), was equivalent to 20,586€, slightly less than the initial capital (24,101€). The decrease of capital was mainly because a number of inhalers were expired or provided free-of-charge (6,091€) and because part of the fund was used to procure other elements required for the management of asthma (4,338€). Thanks to a RDF, Benin maintained an uninterrupted supply of essential asthma medicines in asthma pilot sites from 2008-2013.
The Benin experience demonstrated that in countries where universal health coverage was not yet in place, establishment of a RDF may help maintain an uninterrupted supply of essential medicines.
贝宁于2008年设立了用于基本哮喘药物的循环药物基金（RDF）。我们评估了该RDF的运作情况，并评估了2008年至2013年期间哮喘药物供应是否中断。
我们回顾了设立RDF的过程。我们评估了哮喘药物的成本和销售价格、RDF采购哮喘药物及其他工具的支出、向患者销售药物产生的收入以及截至2013年1月31日的资金余额。我们调查了2008 - 2013年期间基本哮喘药物供应是否中断。
最初注入RDF的赠款总额为24,101欧元。截至2013年1月31日，RDF的资金，包括RDF银行账户中的存款（8,114欧元）和库存吸入器的价值（12,172欧元），相当于20,586欧元，略低于初始资金（24,101欧元）。资金减少主要是因为一些吸入器过期或免费提供（6,091欧元），以及部分资金用于采购哮喘管理所需的其他物品（4,338欧元）。得益于RDF，贝宁在2008 - 2013年期间在哮喘试点地区维持了基本哮喘药物的不间断供应。
贝宁的经验表明，在尚未实现全民健康覆盖的国家，设立RDF可能有助于维持基本药物的不间断供应。
